Patents by Inventor John A. Smoliga

John A. Smoliga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2?,3?-e] [1,4]diazepin-6-one
    Patent number: 7309700
    Abstract: Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2?,3?-e] [1,4]diazepin-6-one.
    Type: Grant
    Filed: March 18, 2005
    Date of Patent: December 18, 2007
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Carl A. Busacca, Michael Cerreta, Richard Varsolona, John Smoliga, Jon Lorenz, Jana Vitous
  • Stable Sertraline Hydrochloride Formulation and Method
    Publication number: 20060257475
    Abstract: Pharmaceutically stable solid pharmaceutical dosage forms of sertraline hydrochloride Form II and Form V polymorphs formed by direct compression.
    Type: Application
    Filed: August 17, 2006
    Publication date: November 16, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Julia ECONOMOU, Andrea McPhillips, John Smoliga, Randall Wilson
  • Polymorphs
    Patent number: 7091340
    Abstract: Disclosed are polymorphs of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea and processes from making the same.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: August 15, 2006
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: John A. Smoliga, Jana Vitous
  • Crystalline forms of 5, 11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one
    Publication number: 20050222134
    Abstract: Dihydrate and anhydrous crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2?,3?-e] [1,4]diazepin-6-one.
    Type: Application
    Filed: March 18, 2005
    Publication date: October 6, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Carl Busacca, Michael Cerreta, Richard Varsolona, John Smoliga, Jon Lorenz, Jana Vitous
  • Polymorphs
    Publication number: 20050137195
    Abstract: Disclosed are polymorphs of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea and processes from making the same.
    Type: Application
    Filed: December 13, 2004
    Publication date: June 23, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: John Smoliga, Jana Vitous